Published on 26/04/2026
Analyzing Non Risk-Based Sampling Plans During Internal Audits: A Root Cause Investigation
In pharmaceutical manufacturing, the integrity of raw material sampling is pivotal for ensuring product quality and compliance with Good Manufacturing Practices (GMP). When an internal audit reveals that sampling plans are not risk-based, it signals potential vulnerabilities in supplier control and material handling processes. This article presents a comprehensive approach to investigating and addressing such deviations, enabling professionals to frame effective corrective actions and preventive measures.
Participants in this investigation will gain insight into the structured methodologies required to identify root causes of non-conformance in sampling procedures. A focus on actionable solutions based on real-world scenarios will help ensure that quality control (QC) and quality assurance (QA) practices align with regulatory expectations.
Symptoms/Signals on the Floor or in the Lab
During internal audits or routine QC checks, several symptoms may indicate deficiencies in the sampling plan. These can include:
- Inconsistent Sampling Procedures: Evidence of varying methods of raw material collection across different batches.
- Failed Acceptance Criteria:
Identifying these symptoms early can significantly mitigate risks associated with raw material quality and ensure compliance with both internal standards and regulatory requirements.
Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)
Several factors might contribute to inadequate risk-based sampling plans. These can be categorized as follows:
| Category | Likely Causes |
|---|---|
| Materials | Inconsistent quality from raw material vendors; unknown shelf life or unstable storage conditions. |
| Method | Lack of standard operating procedures (SOPs); outdated sampling methodologies. |
| Machine | Equipment malfunction during sampling; calibration issues leading to measurement inaccuracies. |
| Man | Insufficient training for personnel on risk assessment; human errors during the sampling process. |
| Measurement | Inadequate testing methods; lack of alignment with regulatory guidelines during material analysis. |
| Environment | Uncontrolled environmental conditions affecting raw materials; inadequate storage protocols. |
Immediate Containment Actions (first 60 minutes)
In response to a deviation noted during the internal audit, immediate containment actions should focus on minimizing risk and protecting product integrity:
- Stop Production: Halt all operations involving the affected raw materials to prevent further impact.
- Isolate Affected Materials: Safely store and clearly label any raw materials associated with the deviation to prevent their use.
- Notify All Relevant Personnel: Inform QA, QC, and management teams about the deviation for immediate collaboration.
- Gather Initial Evidence: Document any relevant anomalies or irregularities observed during the audit process, including samplings logs and test results.
Taking these steps promptly ensures that potential risks are contained while a thorough investigation is initiated.
Investigation Workflow (data to collect + how to interpret)
The investigation for a non risk-based sampling plan should follow a structured workflow. Here are the steps and types of data to collect:
- Data Collection: Gather all relevant sampling protocols, testing results, and materials specifications.
- Interviews: Conduct interviews with personnel involved in the sampling process to gain insights into practices and training.
- Audit Logs: Examine previous audit logs for patterns or recurring issues related to sampling.
- Supplier Quality Records: Review vendor qualifications and any performance metrics associated with their material quality over time.
When interpreting collected data, look for trends or inconsistencies that can point to the root cause. For instance, repeated supplier failures or sampling errors may signal systemic issues that need addressing.
Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which
Three widely recognized root cause analysis tools suitable for addressing non risk-based sampling plans include the 5-Why, Fishbone Diagram, and Fault Tree Analysis:
- 5-Why Analysis: Ideal for identifying the fundamental cause by asking “why” multiple times, leading to deeper insights.
- Fishbone Diagram: Useful for categorizing potential causes within the six ‘M’s: Materials, Machines, Methods, Manpower, Measurements, and Environment.
- Fault Tree Analysis: A more complex evaluation best used for high-risk scenarios, where a graphical representation helps map out potential failure points and relationships.
Choosing the right tool depends on the complexity of the issue being addressed and the depth of analysis required. For simpler deviations, a 5-Why may suffice, while more complex issues may necessitate the Fishbone or Fault Tree methodologies.
CAPA Strategy (correction, corrective action, preventive action)
Once the root cause has been identified, the Corrective and Preventive Action (CAPA) strategy should be established:
- Correction: Address the immediate deviation by ensuring that all affected materials are accounted for and either re-sampled or disposed of properly.
- Corrective Action: Revise and enhance sampling protocols to include risk-based methodologies. Implement training sessions for personnel emphasizing these changes.
- Preventive Action: Establish ongoing monitoring practices to ensure that sampling practices remain aligned with risk assessments and FDA guidance like [FDA’s Guidance for Industry: Quality Systems Approach to Pharmaceutical CGMP Regulations](https://www.fda.gov/media/136195/download).
This dual approach helps not only rectify the existing problems but also fortifies processes against future deviations.
Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)
A robust control strategy is essential for maintaining compliance following the implementation of any changes. Recommended actions include:
Related Reads
- Raw Material Variability and Supplier Risk? Control Strategy Solutions for APIs and Excipients
- Raw Materials & Excipients Management – Complete Guide
- Statistical Process Control (SPC): Utilize SPC methods to monitor raw material sampling processes continuously, allowing for the detection of variations early.
- Trending Analysis: Regularly assess historical data for trends in sampling performance and OOS results that could indicate underlying issues.
- Alerts and Alarms: Set up systems for alerts or alarms when key sampling parameters deviate from established ranges.
Adopting these strategies can automate quality checks and help maintain standards throughout the operational processes, ensuring ongoing compliance with GMP inspection expectations.
Validation / Re-qualification / Change Control impact (when needed)
Modifications to sampling plans might necessitate extensive validation and change control procedures:
- Validation: New sampling techniques or methodologies should undergo validation to confirm their effectiveness and compliance with relevant guidelines.
- Re-qualification: Equipment or methods used in sampling may require re-qualification based on changes in protocols.
- Change Control: Follow change control procedures for any substantial modifications to processes or suppliers to maintain a consistent degree of oversight.
Documenting these activities thoroughly is crucial for demonstrating adherence to regulatory standards during inspections.
Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)
For successful audits following deviations stemming from non risk-based sampling plans, maintaining comprehensive records is essential:
- Sampling Records: Maintain detailed records of all sampling activities, including methods and outcomes.
- Batch Production Records: Ensure batch records are thorough and include any OOS results and subsequent actions taken.
- Deviation Reports: Document all investigations, findings, and CAPA activities related to deviations thoroughly to present as evidence during inspections.
A well-documented evidentiary trail can effectively demonstrate compliance and operational integrity to inspectors from regulatory bodies such as the FDA, EMA, and MHRA.
FAQs
1. What is a risk-based sampling plan?
A risk-based sampling plan focuses on identifying and prioritizing risks associated with raw materials to determine how and when sampling should be conducted more effectively.
2. Why is risk assessment important in supplier qualification?
Risk assessment helps to identify vulnerabilities and improve the quality and safety of materials sourced from suppliers, ensuring robust vendor management.
3. How can we improve training for personnel involved in sampling?
Implement regular training sessions focused on sampling protocols, emphasizing risk assessments, and incorporating real-case scenarios to reinforce concepts.
4. What should be included in sampling records?
Sampling records should document the date, time, method, personnel involved, results, and any deviations observed during the process.
5. How often should we review and update our sampling protocols?
Sampling protocols should be reviewed annually or when significant changes occur, such as new suppliers, methods, or regulations.
6. What documentation is essential for inspection readiness?
Essential documentation includes sampling records, deviation reports, corrective actions, training records, and batch production records.
7. When should I conduct a root cause analysis?
Root cause analysis should be conducted whenever there is a deviation or an increase in failure rates related to critical quality attributes.
8. How can statistical process control benefit sampling processes?
Statistical process control allows for the real-time monitoring of sampling processes, enabling timely detection of issues and preventing batch failures.